Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7269903

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,681,403,000 JPY
-1,929,986,000 JPY
Non-operating income
Non-operating income
45,966,000 JPY
32,208,000 JPY
Non-operating expenses
Non-operating expenses
28,473,000 JPY
16,038,000 JPY
Ordinary profit (loss)
-1,663,911,000 JPY
-1,913,816,000 JPY
Extraordinary income
Extraordinary income
JPY
136,000 JPY
Extraordinary losses
Extraordinary losses
17,104,000 JPY
21,898,000 JPY
Profit (loss) before income taxes
-1,681,015,000 JPY
-1,935,578,000 JPY
Income taxes - current
3,763,000 JPY
2,926,000 JPY
Profit (loss)
-1,684,778,000 JPY
-1,684,778,000 JPY
-1,684,778,000 JPY
-1,684,778,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY
-1,938,505,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.